Objectives/Hypothesis: Dysphagia and esophageal stricture are frequent consequences of treatment for head and neck cancer. This study examines the effectiveness of the anterograde-retrograde rendezvous procedure and serial dilations in reestablishing esophageal patency to allow return to oral diet and gastrostomy tube removal in a cohort of patients with complete or near-complete esophageal stricture following nonsurgical cancer treatment.
INTRODUCTION
Pharyngoesophageal toxicities have been increasingly encountered 1 since the first radiation-induced esophageal stricture was reported in 1968. 2 It is now estimated that >40% of head and neck cancer patients who receive radiation develop clinically significant treatmentattributable dysphagia, 1 and between 3.3% and 23% develop esophageal strictures. 1, 3, 4 Strictures originate from sufficient mucosal injury or mucositis during treatment to later result in coalescence of approximating pharyngeal or esophageal mucosa and formation of partial or complete obstruction. 5 Pathophysiologically, coalescence and obstruction is mediated by fibrosis caused by obliterative endarteritis, which leads to esophageal wall ischemia. In addition to fibrosis, muscular activity controlling peristalsis becomes disordered.
Several factors have been associated with stricture development, including higher radiation dose to the esophagus, 3, 6 larynx, 7 and pharyngeal constrictors 8 ; certain fractionation schedules 9 ; pretreatment presence of nasogastric or gastrostomy tube 3, 10 ; combined therapy (i.e., radiation 1 chemotherapy) 1, 4, 9, 11 ; laryngeal or hypopharyngeal primary cancers 1, 9 ; female gender 9 ; highgrade mucositis 12 ; and taxane-based chemotherapy. 4, 13 However, there is still considerable variability in reported risk factors, and their relative contribution to stricture formation are not fully elucidated.
Regardless of etiology, quality-of-life consequences of esophageal strictures are significant, 14 particularly for patients with high-grade strictures who are routinely gastrostomy tube dependent and require repeated dilations in attempts to reestablish a patent alimentary tract. Treatment of high-grade strictures is challenging, and thus several different approaches have been attempted. [15] [16] [17] [18] The ultimate goal of therapy is to return patients to an oral diet that permits gastrostomy tube removal. Additionally, improving swallowing sufficiently to allow passage of saliva also represents a substantial improvement in patient quality of life. To date, few studies have reported on long-term effectiveness of serial dilation at achieving this goal in patients with high-grade esophageal strictures. One recent case series described post-treatment swallowing outcomes for patients dilated for radiation-induced esophageal strictures, but did not report data specifically for those with high-grade strictures. 19 Another study, focusing only on highgrade strictures, achieved a 60% gastrostomy tube removal rate with combined anterograde and retrograde dilation approach. 20 The aim of this study was to measure the effectiveness of serial dilations in reestablishing sufficient esophageal patency to allow oral intake for sustenance and/or enable gastrostomy tube removal in a cohort of patients with complete or near-complete esophageal strictures following nonsurgical treatment for head and neck cancer.
MATERIALS AND METHODS
This study was performed in accordance with the Declaration of Helsinki, Good Clinical Practice, and was approved by the Vanderbilt Institutional Review Board (IRB#120094).
Patient Population
Included were head and neck cancer patients with pathologically confirmed squamous cell carcinoma treated with radiation therapy, with or without concurrent chemotherapy, who presented to the Digestive Disease Center between 2006 and 2012 with complete or near-complete esophageal stricture. Complete esophageal stricture was defined as no identifiable lumen on endoscopic evaluation, whereas near-complete esophageal stricture refers to a stricture patency less than or equal to the 4 mm pediatric endoscope diameter. Additionally, those with recurrent disease or having had extirpative surgery for their head and neck cancer were excluded. Patients with lower grade strictures presenting for dilation were also excluded from this analysis.
Technique
Patients underwent esophageal evaluation and dilation under general anesthesia. The dilation algorithm described is shown in Figure 1 . Degree of luminal occlusion was confirmed by traditional endoscopy employing a 9-mm endoscope followed by a 4-mm endoscope via the anterograde approach. If occlusion was not complete, an endoscope balloon (controlled radial expansion [CRE] non-wire guided; Boston Scientific, Marlborough, MA) was advanced through the opening, and if any resistance was encountered, then a combined anterograde and retrograde approach was used as described below. If no resistance to the CRE balloon was encountered, the stricture was routinely dilated to 12 mm and subsequently inspected by anterograde esophagoscopy initially using the 4-mm and then the 9-mm endoscope.
When complete occlusion was encountered, the percutaneous endoscopic gastrostomy (PEG) tube was removed, and a 4- mm transnasal esophagoscopy scope advanced into the stomach. The gastroesophageal junction was identified and intubated, and retrograde esophagoscopy used to confirm complete luminal occlusion (Fig. 2a) . Employing combined anterograde rigid cervical esophagoscopy by otolaryngology and retrograde esophagoscopy allowed for transillumination to localize the most optimal site for puncture. A Savary guidewire (Cook Endoscopy, WinstonSalem, NC) was used to puncture the occluded lumen either via retrograde or anterograde approach. The wire was then carefully pulled through the mouth and the esophagus to the stomach and out of the gastrostomy. In both approaches, dilations occurred from above using Savary dilators up to 36F. Upon completion of dilations, the PEG tube was replaced and patency of the cervical esophagus confirmed by an anterograde esophagoscopy using a 9-mm endoscope (Fig. 2b) . In all cases, serial Savary dilation (Cook Endoscopy) was performed initially 1 week postprocedure and then every 2 weeks, followed by monthly dilation to ensure continued luminal patency. There was fair consistency in recannulation techniques used; however, variability, adaptability, and creativity were often necessary based on degree and morphology of each strictured esophageal segment. CARD is often referred to and is herein used synonymously with the rendezvous procedure. The primary outcome was return to oral diet (no restrictions or sustenance with soft food) and/or gastrostomy tube removal due to improved swallow.
Data Collection

Interviews
Prospective semistructured interviews were performed to determine current swallowing function and actual patient experience with esophageal stricture. Interviews were semistructured in that specific questions were asked of all patients, with additional opportunities for patients to voluntarily and independently share their own perspectives. These were performed either in person or via phone depending on patient preference. Patients completed interviews voluntarily and were able to stop at any point. Patients were asked about the onset of dysphagia in relation to cancer treatment, when stricture was diagnosed, dilation effectiveness, current diet, whether they were still gastrostomy tube dependent, and if it had been removed. Duration of follow-up was defined as either time from first dilation to phone interview, or if a phone interview was unobtainable, time from first to last follow-up visit.
Analysis
All data were recorded in the secure Web-based Digestive Disease Center REDCap (Research Electronic Data Capture) (1 UL1 RR024975 NCRR/NIH). REDCap is an application designed to support data capture for research studies providing: 1) an intuitive interface for validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for importing data from external sources. 21 There was strict control and supervision of the data entry and access for this study.
All statistical analyses were performed using Stata MP version 12 software (StataCorp, College Station, TX). Univariate analysis for continuous variables used median and interquartile range (IQR) and percentages for binary variables. Fisher exact and rank sum tests were used, where appropriate, to compare dilation effectiveness between patients with complete and near-complete strictures. Within these groups, parameters associated with successful return to oral diet (i.e., no limitations or soft diet) and/or gastrostomy tube removal were assessed. Secondary outcomes included patient-reported satisfaction with swallow (scale: 1-2 5 unsatisfied, 3 5 moderately satisfied, 4-5 5 very satisfied) and whether they have experienced improvement from baseline dysphagia. Table I ). The remainder (n 5 31) had lower-grade strictures and thus did not meet inclusion criteria. The larynx was the most common cancer site (12/24) followed by oropharynx (11/ 24) and oral cavity (1/24). Of those with available staging information (15/24), most (13/15) were treated for advanced cancer (stage III/IV). No patients had stage IVC cancer. In all, 91.7% (22/24) of patients had gastrostomy tubes at presentation for dilation, which were placed during (11/24), before (7/24), or after (4/24) their cancer treatments. A quarter of ever smokers continued to smoke through treatment for their stricture (4/16). Patients presented for first dilation a median of 8.0 months (IQR 5 6.4-20.7 months) after gastrostomy tube placement, and of those with known treatment end dates (n 5 18) a median of 9.5 months (IQR 5 5-21 months) after completing cancer treatment.
RESULTS
Of
Cancer Treatment
All patients were treated with definitive radiation therapy (24/24), and most (87.5%; 21/24) received concurrent chemotherapy (21/24) ( Table I) . Specific chemotherapy data were available for 12/21 patients, of which 9/12 had combined taxane and platinum-based therapy. Intensity modulated radiation therapy (IMRT) was used in 12/19 (63.2%) patients who had available radiation data, with the remainder undergoing conventional threedimensional conformal external beam radiation (7/19). For the remaining five patients, medical records and/or patients confirmed receiving definitive radiation therapy, though detailed records were not available for review. Overall, the median maximum IMRT dose to the cricopharyngeus/upper esophageal sphincter (UES) was 7,080 cGy (IQR 5 6,300-7,336 cGy; n 5 10). Similarly, for patients who received conventional radiation therapy, this entire area was well within the region prescribed of 7,000 cGy, and thus received at least this dose and likely higher.
Stricture Management
In order, the initial endoscopic approach to stricture was anterograde (62.5%) followed by combined approach (37.2%). Strictures were universally present at or within 2 cm of the UES and were complete (no identifiable lumen) in 50% of patients (12/24) . Otolaryngology assist was required for CARD in 10/12 complete strictures. All patients were successfully dilated at initial endoscopy. Overall, this population required a median of 9 dilations (IQR 5 6-20 dilations; range 5 2-37 dilations) over a median follow-up of 21.0 months (IQR 5 11.9-30.4 months) (Table I) .
Safety
Of 276 dilations performed in this population, there was a 1.8% complication rate that consisted of microperforations (n 5 2 pneumomediastinum [dilations 1, 2]; n 5 2 subcutaneous air [dilation 3, 5]), which were managed conservatively with overnight observation, and one major complication of delayed bilateral vocal fold paralysis that occurred after cervical esophageal stent placement (dilation 8) requiring tracheostomy. In all, 21.7% of patients experienced a complication with risk being independent to the degree of their obstruction (near complete 16.7% vs. complete 25%, P 5 1.00). All perforations occurred within the first five dilations. 
Primary Outcomes
All patients with complete stricture (12/12) and 75% of those with near-complete stricture (10/12) presented with gastrostomy tubes at the time of initial dilation (P 5.48) (Table II) . Patients with complete strictures presented for the first dilation a median of 11 months earlier after cancer treatment than those with near-complete strictures (median 6 months [IQR 5 5-10 months] compared to 17 months [IQR 5 11-48.5 months], P 5.07). After dilations, 42% of patients (10/24) were able to return to a full oral diet without limitations. Achievement of this outcome was independent of whether the stricture was complete (P 5.67). Among those with complete stricture, 33.3% (4/12) had their gastrostomy tube removed after dilations reestablished the ability to maintain oral nutrition, whereas 50% with near-complete stricture (5/10) had them removed as a result of dilations. Patients who eventually had their gastrostomy tube removed presented for dilation earlier, but not significantly more so than those who remained dependent at the time of last follow-up (removed: 6 months [IQR 
Secondary Outcomes
Of the 24 patients in the cohort, 18 were alive at the time of the study, and 17 participated (one declined interview) in semistructured interviews. Nearly all patients (94.1%, 16/17) reported improved swallow due to dilations, and 68% were "moderately" to "very satisfied" with their swallowing result. All interviewed patients were able to swallow their own saliva. Not surprisingly, those who were less satisfied were only able to take soft foods (n 5 2) or swallow their own saliva (n 5 3).
DISCUSSION
Pharyngoesophageal toxicities from radiation with or without concurrent chemotherapeutic treatment (CRT) of the head and neck cancer are frequent, appear to be increasing, 1 and can be devastating. Here we explore the effectiveness of serial dilation of CRT-related complete and near-complete esophageal strictures. In total, 55 symptomatic esophageal strictures were treated at our center between 2006 and 2012, of which 24 were high grade (i.e., complete or near complete), and sufficient follow-up was available to assess treatment effectiveness. The success rate of recannulation was 100% with otolaryngology assisting with rigid esophagoscopy in 83% of complete strictures. Nonetheless, despite successful recannulation, reestablishment of oral diet and removal of gastrostomy tube was achieved in 42% overall, and 33% and 50%, respectively, among patients with complete and near-complete esophageal stricture. Of those interviewed, 68% were "very satisfied" or "moderately satisfied" with swallowing after and during treatment. Overall, 94.1% admitted to significantly better swallowing than they had before initiating dilations.
Treating this patient population is complicated, evidenced by the multitude of approaches described in the literature. [15] [16] [17] [18] Despite attention to radiation-induced stricture and its treatment, little is known about the long-term effectiveness of dilation techniques on swallowing and patient satisfaction in high-grade strictures. Presumably, the low incidence of high-grade stricture has resulted in most treatment outcomes studies being relatively small (n 15), [22] [23] [24] [25] including case reports. [26] [27] [28] [29] However, two larger single institutional case series performed over a similar period as ours (2000-2008) do provide some insight. In one study of 45 patients who underwent CARD, resumption of oral intake occurred in 36/46 (80%), with gastrostomy tube removal possible in 27/45 (60%) in a median 116 weeks. 20 Failure (gastrostomy tube dependency and nothing by mouth (NPO)) was recorded in 9/45 (20%). Another more recent large caseseries of 111 patients with stricture included a subset of patients similar to ours: 20 with esophageal patency <5 mm (near complete) and 23 with complete esophageal stricture. 19 Although the results were not specifically reported for this severe subset, the study's overall results are enlightening. Among their entire cohort (i.e., all stricture severities), an average 2.4 dilations were used per patient (range, 1-8), resulting in 78% and 88% having their gastrostomy tube removed at the 1-and 2-year follow-up, respectively. Interestingly, 4/23 (17%) with complete stricture remained gastrostomy dependent despite repeated dilations with 2/4 becoming diet independent at 18 and 24 months after starting treatments. In contrast, our high-grade stricture patients required a median of nine dilations over a 21-month median period resulting in a 42% PEG removal rate.
Discrepancy between the current study's results and those of Chapuy et al. is interesting, especially because similar endoscopic dilation techniques were applied. 19 First, only 47% of strictures treated were classified as high grade by our criteria. Thus, the majority of the strictures reported on were less severe, more easily dilated, and therefore more amenable to durable dilation results. However, perhaps the most important differentiating factor between both Chapuy et al.'s 19 and Goguen et al.'s 20 outcomes were that their stricture patients presented a median 3.6 and 4.2 months earlier after cancer treatment: 5.9 months and 5.1 months versus 9.5 months in our series. These series reported higher gastrostomy tube removal rates, but were not specific to high-grade strictures in one, whereas the other reported a 60% rate 20 with substantially fewer required dilations (median 3 vs. 9). Earlier recognition may prevent more severe strictures from developing and also translate into dilations of less fibrotic and more easily distensible segments. Supporting this assertion is the finding that when initial dilation occurred >6 months after CRT, there was a 2.4-fold increased odds of dilations failing to restore sufficient oral nutrition to allow gastrostomy tube removal. 19 This corresponds with data herein indicating that patients who were able to achieve gastrostomy removal presented a median of 4 months earlier than those who remained dependent. Although not a statistically significant difference (P 5.33), likely due to inadequate statistical power, this finding raises the question whether early detection of strictures results in better patient outcomes.
Another distinction between our study and Chapuy et al.'s was the distribution of primary site; laryngeal cancers represented 50% in our series compared to 13.5% in theirs. 19 Moreover, their population included 35% advanced T stage (T3/4) compared to 13/15 of our population. In this study, 63% of patients with highgrade esophageal strictures were treated with IMRT. Although IMRT is a useful technique to help reduce normal tissue toxicity and still deliver comparable dose to the tumor, 30 dose inhomogeneity can result in "hot spots" within the treatment volume or closely associated surrounding normal structures. In our cohort, with a larger percentage of patients having laryngeal primaries, the proximal inferior constrictors and esophagus are at increased risk of high-dose exposure compared to conventional radiation techniques. Dose greater than 50 to 60 Gy to the larynx and inferior constrictors has been associated with significantly increased risk of stricture. 4, 7, 31 Studies comparing conventional radiation therapy to IMRT are mixed, with some reporting better swallowing with IMRT, 32, 33 whereas others found no added benefit. 34, 35 One recent study found that IMRT increased the risk of cervical esophageal stricture, though the significance may be overstated, as there was no incidence of stricture and somewhat decreased use of concurrent chemotherapy in the patients who underwent conventional treatment. 36 Attempts to limit the constrictor and esophagus dose (when not involved) below 50 Gy becomes an important consideration in IMRT planning, though this may often be challenging when treating laryngeal tumors regardless of radiation technique. In all, these findings highlight the important role that radiation dose and target volume play in the pathogenesis of pharyngoesophageal sequelae. 5 Some evidence suggests that tobacco use is a risk factor for esophageal stricture formation. Specifically, patients treated with endoscopic mucosal resection of neoplastic Barrett's esophagus had nonsignificantly increased odds of developing esophageal stricture if patients had greater than or equal to 25 pack-years of smoking (adjusted odds ratio: 3.33, 95% confidence interval: 0.929-12.1). 37 Another study of head and neck cancer patients treated with both total laryngectomy and radiation therapy found an incidence of esophageal stricture of 33%, and alcohol and tobacco use were contributing factors to formation. 38 Another study failed to demonstrate an increased risk of stricture formation based on smoking status. 12 Perforations were the most common complication, which occurred in 1.8% of the 276 procedures performed and impacted 21% of patients within the first five dilations. This compares favorably with the 4% rate reported by Chapuy et al. 19 and 29% rate in another series of 63 CARD procedures. 20 Small perforations were most common and were treated conservatively with overnight observation and monitoring. Perforation rates in nearcomplete and complete esophageal stricture recannulation are expectedly higher than the 0.033% reported for routine esophagogastroduodenoscopy (EGD) 39 and 0.4% for EGD with dilation. 40 They occur when the guidewire is passed through the blind pouch separating the proximal and distal segments. Often the strictured segment is quite narrow, thus the wire may be passed extraluminally before passing into the opposing pouch. These perforations can predispose toward mediastinitis, and therefore overnight observation with chest imaging and appropriate surgical consultation is recommended if significant neck or chest crepitus is encountered. The only major complication, not previously described in the literature, was delayed bilateral vocal fold paralysis occurring after polyflex stent placement in the cervical esophagus. This required urgent tracheotomy and hospitalization. At last examination, approximately 1 year later, vocal fold paralysis persisted.
This retrospective cohort study demonstrates the difficulty in managing high-grade radiation-induced esophageal strictures and found that independence from gastrostomy tubes was possible in 42% of patients. Despite several important findings, this study does have limitations that deserve mention. First, the Digestive Disease Center is a tertiary care center, and therefore patients presented from a large catchment area. Thus, most patients were treated at outside institutions and not all clinical data were accessible or retrievable for review and analysis. This included information on staging, chemotherapy regimen, and radiation schedules. Second, due to incomplete records and low incidence of high-grade strictures, the cohort was relatively small, potentially providing inadequate statistical power to identify important associations and to perform multivariate analysis.
CONCLUSION
Radiation-induced esophageal strictures cause significant dysphagia and, in severe cases, gastrostomy tube dependence among head and neck cancer patients. This study demonstrates that, even in cases of complete or near-complete stricture, recannulation is possible, and that through serial dilations over 40% of patients can have their gastrostomy tube removed, and over 90% have improved quality of life with the ability to swallow their own saliva. Several factors appear to impact likelihood of return to oral diet and gastrostomy tube removal, but in this study, only patients with a history of smoking had a significantly lower likelihood of return to complete oral sustenance. Validity of this and other associations is uncertain, and future work is required to better understand why these strictures develop and how these high-grade strictures can best be treated.
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